Results 231 to 240 of about 3,069,601 (247)

Recent advances in understanding the role of sex hormone receptors in urothelial cancer. [PDF]

Oncol Res
Elahi Najafi MA, Matsukawa T, Miyamoto H.   +2 more
europepmc   +1 more source

Staging metastatic urothelial cancer with Nectin-4 imaging using Gallium-68-N188 PET/CT. [PDF]

BJU Int
Miederer M, Pretze M, Abbate E, Hartig A, do Mar Ferreira Machado J, Böhm K, Sommer U, Hoberück S, Bundschuh RA, Kotzerke J, Thomas C.   +10 more
europepmc   +1 more source

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer. [PDF]

ESMO Real World Data Digit Oncol
Bosveld J, Suelmann BBM, Bijlsma MJ, Franken MD, Aben KKH, ProBCI Study Group, Meijer RP, Richters A.   +7 more
europepmc   +1 more source

Novel Pretreatment Autoantibodies Correlate with Enfortumab Vedotin-Related Dermatologic Events in Patients with Advanced Urothelial Cancer. [PDF]

Cancer Res Commun
Vlachou E, Johnson BA, McConkey DJ, Hahn NM, Jing Y, Russell S, Stairiker D, Rosen A, Casciola-Rosen LA, Hoffman-Censits J.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Cancer, 2022
Yousef Zakharia, Albert Jang
exaly  

Treatment of muscle-invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
William K. Oh, Matthew D Galsky, Vaibhav G Patel   +2 more
exaly  

Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer

International Journal of Molecular Sciences, 2021
Yi-Fang Yang, Hao-Wen Chuang, Yu-Chan Chang   +2 more
exaly